• Citer

A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: Clinical and immunological findings

par Oudard, Stéphane;Rixe, Olivier;Beuselinck, Benoit;Linassier, Claude;Banu, Eugeniu;Machiels, Jean Pascal;Baudard, Marion;Ringeisen, François;Velu, Thierry ;Lefrere-Belda, Marie-Aude;Limacher, Jean-Marc;Fridman, Wolf Herman;Azizi, Michel;Acres, Bruce;Tartour, Eric
Référence Cancer immunology and immunotherapy, 60, 2, page (261-271)
Publication Publié, 2011-02

Article révisé par les pairs

• Détails
• Contenu

Titre:	A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: Clinical and immunological findings
Auteur:	Oudard, Stéphane; Rixe, Olivier; Beuselinck, Benoit; Linassier, Claude; Banu, Eugeniu; Machiels, Jean Pascal; Baudard, Marion; Ringeisen, François; Velu, Thierry; Lefrere-Belda, Marie-Aude; Limacher, Jean-Marc; Fridman, Wolf Herman; Azizi, Michel; Acres, Bruce; Tartour, Eric
Informations sur la publication:	Cancer immunology and immunotherapy, 60, 2, page (261-271)
Statut de publication:	Publié, 2011-02
Sujet CREF:	Allergie et immunopathologie
	Cancérologie
	Immunologie
Mots-clés:	Cytokines
	Immune response
	MUC1
	Renal cell carcinoma
	TG4010
	Vaccine
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0340-7004
	info:doi/10.1007/s00262-010-0935-9
	info:scp/79151471986
	info:pmid/21069322